Get the Stockscreener App
1.37
2.14%
-0.03
Boundless Bio Inc stock is traded at $1.37, with a volume of 49,136.
It is down -2.14% in the last 24 hours and up +11.38% over the past month.
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.
See More
Previous Close:
$1.40
Open:
$1.38
24h Volume:
49,136
Relative Volume:
0.43
Market Cap:
$30.67M
Revenue:
-
Net Income/Loss:
$-64.39M
P/E Ratio:
-0.4744
EPS:
-2.8877
Net Cash Flow:
$-56.24M
1W Performance:
-8.05%
1M Performance:
+11.38%
6M Performance:
-14.64%
1Y Performance:
-54.03%
1-Day Range:
$1.3201
$1.40
1-Week Range:
$1.3201
$1.52
52-Week Range:
$1.00
$3.75
Boundless Bio Inc Stock (BOLD) Company Profile
Name
Boundless Bio Inc
Sector
Industry
Phone
(858) 766-9912
Address
10955 ALEXANDRIA WAY, SAN DIEGO
Compare BOLD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BOLD
Boundless Bio Inc
|
1.37 | 31.34M | 0 | -64.39M | -56.24M | -2.8877 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Boundless Bio Inc Stock (BOLD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Initiated | H.C. Wainwright | Buy |
| May-28-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-13-24 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-22-24 | Initiated | Guggenheim | Buy |
| Apr-22-24 | Initiated | Leerink Partners | Outperform |
| Apr-22-24 | Initiated | Piper Sandler | Overweight |
View All
Boundless Bio Inc Stock (BOLD) Latest News
Is this a good reentry point in Boundless Bio Inc.2025 Fundamental Recap & Short-Term High Return Strategies - newser.com
Will Boundless Bio Inc. stock benefit from infrastructure spendingJuly 2025 Gainers & Long-Term Safe Investment Ideas - newser.com
Volatility clustering patterns for Boundless Bio Inc.2025 Price Action Summary & Risk Adjusted Buy/Sell Alerts - newser.com
What analyst consensus says on Boundless Bio Inc. stock2025 Pullback Review & Fast Entry High Yield Stock Tips - newser.com
Can Boundless Bio Inc. stock sustain institutional interest2025 Year in Review & Stock Timing and Entry Methods - newser.com
How to build a custom watchlist for Boundless Bio Inc.Weekly Trade Recap & Risk Controlled Swing Trade Alerts - newser.com
Can Boundless Bio Inc. stock outperform in 2025 bull marketJuly 2025 Levels & Reliable Entry Point Alerts - newser.com
Is Boundless Bio Inc. stock positioned for digital transformationWeekly Loss Report & Technical Analysis for Trade Confirmation - newser.com
Boundless Bio Inc. stock trend outlook and recovery pathJuly 2025 Price Swings & Free Expert Approved Momentum Trade Ideas - newser.com
Market reaction to Boundless Bio Inc.’s recent news2025 Sector Review & Community Consensus Trade Alerts - newser.com
Is Boundless Bio Inc. a candidate for recovery playWeekly Stock Summary & Safe Entry Zone Identification - newser.com
How Boundless Bio Inc. stock valuations compare to rivals2025 Top Gainers & Verified Short-Term Trading Plans - newser.com
How to monitor Boundless Bio Inc. with trend dashboardsJuly 2025 Analyst Calls & Real-Time Market Sentiment Reports - newser.com
Is Boundless Bio Inc. stock a buy for dividend growthM&A Rumor & Fast Exit Strategy with Risk Control - newser.com
Applying chart zones and confluence areas to Boundless Bio Inc.Risk Management & Technical Pattern Alert System - newser.com
Will Boundless Bio Inc. bounce back from current supportJuly 2025 Analyst Calls & Verified Stock Trade Ideas - newser.com
Detecting support and resistance levels for Boundless Bio Inc.Market Activity Recap & Weekly Momentum Picks - newser.com
Will Boundless Bio Inc. stock go up soonTake Profit & Low Risk Entry Point Tips - newser.com
Boundless Bio Inc Stock (BOLD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):